Revolution Medicines (RVMD) Shares Outstanding (Weighted Average) (2018 - 2026)

Revolution Medicines has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $198.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 5.29% year-over-year to $198.1 million; the trailing twelve-month figure through Mar 2026 stood at $198.1 million (up 5.29% YoY), and the FY2025 full-year result was $190.1 million, up 13.35% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $198.1 million, up from $190.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $198.1 million in Q1 2026, with the low at $74.2 million in Q1 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $137.8 million, with a median of $164.7 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) grew 1.2% in 2022 and jumped 73.71% in 2024.
• Tracing RVMD's Shares Outstanding (Weighted Average) over 5 years: stood at $80.6 million in 2022, then soared by 40.32% to $113.1 million in 2023, then jumped by 48.24% to $167.7 million in 2024, then advanced by 13.35% to $190.1 million in 2025, then gained by 4.19% to $198.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $198.1 million (Q1 2026), $190.1 million (Q4 2025), and $188.7 million (Q3 2025), per Business Quant data.

Peer Comparison